Varicella Zoster Virus-Specific Hyperimmunoglobulin in the Adjuvant Treatment of Immunocompromised Herpes Zoster Patients: A Case Series.

Patrick Terheyden Cord SunderkoetterFranz-Dietmar SöhngenLinda GolleSonja Schimo Ralf BaronChristian MaihöfnerAndreas BinderWolfram Pönisch

Published in: Dermatology and therapy (2023)

This case series demonstrates highly satisfactory treatment effectiveness and tolerability for VZV-IgG in the adjuvant treatment of immunocompromised HZ patients and supports early intensification of HZ therapy in patients at high risk of severe disease progression.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
early stage
peritoneal dialysis
prognostic factors
stem cells
clinical trial
intensive care unit
open label
bone marrow
cell therapy
smoking cessation
extracorporeal membrane oxygenation